Markovian analysisof a stay process in ahospital of third level ofcomplexity
DOI:
https://doi.org/10.17533/udea.rfnsp.709Keywords:
Length of stay, Markov chains, trauma, absorbing barriersAbstract
Downloads
References
(1). Navarro V, Parker R. Models in health servicesplanning. Data handling in epidemiology Lon-don: Oxford University Press, 1970.
(2). Hendriks JC, Satten GA, Longini IM, van Dru-ten HA, Schellekens PT, Coutinho RA, vanGriensven GJ. Use of immunological markersand continuous-time Markov models to estima-te progression of HIV infection in homosexualmen. AIDS 1996;10(6):649-656. DOI: https://doi.org/10.1097/00002030-199606000-00011
(3). Schechter MT, Le N, Craib KJ, Le TN, O’Shaugh-nessy MV, Montaner JS. Use of the Markovmodel to estimate the waiting times in a modi-fied WHO staging system for HIV infection. JAcquir Immune Defic Syndr Hum Retrovirol1995 15;8(5):474. DOI: https://doi.org/10.1097/00042560-199504120-00007
(4). Lu Y, Stitt FW. Using Markov processes to des-cribe the prognosis of HIV-1 infection. MedDecis Making 1994 ;14(3):266-272. DOI: https://doi.org/10.1177/0272989X9401400309
(5). Kuo HS, Chang HJ, Chou P, Teng L, Chen TH.A Markov chain model to assess the efficacy ofscreening for non-insulin dependent diabetesmellitus (NIDDM). Int J Epidemiol 1999;28(2):233-240. DOI: https://doi.org/10.1093/ije/28.2.233
(6). Garg SK, Marshall G, Chase HP, Jackson WE,Archer P, Crews MJ. The use of the Markov pro-cess in describing the natural course of diabeticretinopathy. Arch Ophthalmol 1990;108 (9):1245-1247. DOI: https://doi.org/10.1001/archopht.1990.01070110061025
(7). Schaubel DE, Morrison HI, Desmeules M, Par-sons D, Fenton SS. End-stage renal disease projections for Canada to 2005 using Poisson andMarkov models. Int J Epidemiol 1998; 27: 274-281. DOI: https://doi.org/10.1093/ije/27.2.274
(8). Desmeules M, Schaubel D, Fenton SS, Mao Y.New and prevalent patients with end-stage re-nal disease in Canada. A portrait of the year2000. ASAIO J 1995;41(2):230-233. DOI: https://doi.org/10.1097/00002480-199541020-00021
(9). Duffy SW, Chen HH, Tabar L, Day NE. Estima-tion of mean sojourn time in breast cancer scree-ning using a Markov chain model of both entryto and exit from the preclinical detectable pha-se. Stat Med 1995 30;14(14):1531-1543. DOI: https://doi.org/10.1002/sim.4780141404
(10). Duffy SW, Day NE, Tabar L, Chen HH, SmithTC. Markov models of breast tumor progression:some age-specific results. J Natl Cancer InstMonogr 1997; 22:93-97. DOI: https://doi.org/10.1093/jncimono/1997.22.93
(11). Boult C, Kane RL, Louis TA, Ibrahim JG. Fore-casting the number of future disabled elderlyusing Markovian and mathematical models. JClin Epidemiol 1991;44(9):973-980. DOI: https://doi.org/10.1016/0895-4356(91)90068-K
(12). Biritwum RB, Odoom SI. Application of Mar-kov process modelling to helth status switchingbehaviour of infants. Int J Epidemiol 1995; 24:177-182. DOI: https://doi.org/10.1093/ije/24.1.177
(13). Pérez A, Chan W, Dennis R. Predicción de lalongitud de estancia en pacientes admitidos aunidades de cuidado intensivo en Colombia,usando un modelo Markoviano discreto. En: XIIISimposio de Estadística. Universidad Nacionalde Colombia, Armenia, agosto de 2003.
(14). Valencia M, Morales M, Arroyave ML, Montoya WD, Colorado SM, González G. Factores deriesgo de infección intrahospitalaria en pacientes mayores de 12 años hospitalizados por cau-sa traumática en el Hospital Universitario SanVicente de Paúl, 1999. Trabajo de grado (maes-tría en epidemiología). Universidad de Antio-quia. Facultad Nacional de Salud Pública. Me-dellín, 1999.
(15). Ibáñez J. (Ed). Nuevos avances en la investiga-ción social: la investigación social de segundoorden. Suplementos Anthropos 1990; 22: 130-180.
(16). Ross D, McKeown P. Modelos cuantitativos paraadministración, México: Iberoamericana, 1986.
(17). Prawda J. Métodos y modelos de investigaciónde operaciones. Vol 2. Modelos estocásticos.México, DF: Limusa; 1993.
(18). Caswell Hal. Matrix population models: cons-truction, analysis and interpretation. 2nd ed.Sunderland, Mass: Sinauer Assoc; 2001.
Downloads
Published
How to Cite
Issue
Section
License
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
